By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



7000 Shoreline Court
Suite 371
South San Francisco  California  94080  U.S.A.
Phone: 650-266-1120 Fax: 650-266-1130




Company News
Achaogen (AKAO) Announces New Employment Inducement Grants 6/22/2017 10:45:00 AM
Achaogen (AKAO) Announces Closing Of Public Offering 6/1/2017 11:33:43 AM
Achaogen (AKAO) Initiates C-Scape Clinical Development Program With Phase I Study Of Orally-Administered Antibacterial Candidate 6/1/2017 11:18:57 AM
Achaogen (AKAO) Announces Pricing Of Public Offering Of Common Stock 5/25/2017 11:01:15 AM
Achaogen (AKAO) Release: Plazomicin Granted FDA Breakthrough Therapy Designation 5/24/2017 12:35:22 PM
Achaogen (AKAO) Reports First Quarter 2017 Financial Results and Provides Corporate Update 5/9/2017 10:56:08 AM
Achaogen (AKAO) Receives Investment From The Bill & Melinda Gates Foundation To Develop Antibodies Against Gram-Negative Bacteria 5/5/2017 9:05:56 AM
Achaogen (AKAO) To Host Conference Call And Webcast Of First Quarter 2017 Financial Results On May 8, 2017 5/1/2017 10:16:53 AM
Achaogen (AKAO) Unveils Data Highlighting The Effectiveness Of Plazomicin Against MDR Gram-Negative Bacteria At European Congress Of Clinical Microbiology And Infectious Diseases (ECCMID) 4/24/2017 11:31:33 AM
Achaogen (AKAO) To Present At Needham & Company’s 16th Annual Healthcare Conference 3/30/2017 11:43:23 AM